These new hires will join existing ARCA employees in overseeing the execution of GENETIC-AF, the Company’s Phase 2B/3 clinical trial evaluating Gencaro as a potential treatment for atrial fibrillation.
Sharon Perry, Senior Director Quality, was previously Director of Quality Assurance (QA) at Accera Pharma. Ms. Perry also brings additional relevant QA experience from her prior work at Gilead Sciences, PR Pharmaceuticals and Pfizer.
Jennifer Merriweather, Senior Clinical Program Manager was previously Clinical Program Manager at Gilead Sciences. Ms. Merriweather also brings additional relevant clinical development experience from her work with Myogen, Inc.
Recent ABIO News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/01/2024 08:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:25:09 PM
- ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/01/2024 08:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/01/2024 08:10:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 02:50:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/25/2024 04:15:10 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/22/2024 09:17:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 11:38:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 11:10:32 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:29:01 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/09/2024 09:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 09:01:28 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/05/2024 09:20:16 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 06/18/2024 09:17:29 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/06/2024 08:45:16 PM
- Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm • PR Newswire (US) • 05/22/2024 07:08:00 PM
- ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/25/2024 08:15:00 PM
- Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
- ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
- ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 06:08:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:39:21 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM